Hlscience

239610 · KOSDAQ · ₩239610 · 에이치엘사이언스

₩5,300▼ ₩140 (2.57%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y −43.68%
Market cap
₩29B
Enterprise value
₩27B
P/E
—
P/B
0.4×
Dividend yield
0.0%
ROE
−14.3%
Net margin
−106.8%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−47.7% from the high

₩4,950Today: ₩5,300 – ₩5,490₩10,140

Returns

  • 1W+1.7%
  • 1M−0.4%
  • 3M+0.6%
  • 6M−42.3%
  • YTD−34.5%
  • 1Y−43.7%
Volume today
1,147
1.3× the 20-day average
Traded today
₩6.1M
Listed shares
5,392,115
EPS (12 months)
−₩2,068
Earnings yield −39.0%
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.

Upcoming dates

Full calendar →

🎁 Gift this stock

Send a friend ₩100,000 of paper money in this stock. They get it when they join.

Signals

50Normal
  • BuzzNormalBuzz 50 of 100 (50 is a normal day for this stock).
  • MomentumFlat1.3% over the last month; the price is above its 20-day average.

Signals describe activity, not recommendations. Not financial advice.

Hlscience stock overview

Hlscience (에이치엘사이언스, KRX: 239610) is listed on KOSDAQ, in the Food & Beverage sector. The company is a bio-healthcare technology platform focused on research into new bio-health materials and technologies. Its shares closed at ₩5,300 on Oct 27, 2026, down 2.57% on the day, giving it a market value of ₩29B.

Key facts

Market cap
₩29B
Sector
Food & Beverage
Latest price change
−2.57%
As of
Oct 27, 2026
Main business
The company is a bio-healthcare technology platform focused on research into new bio-health materials and technologies.

Quick answers about Hlscience

What does Hlscience do?
The company is a bio-healthcare technology platform focused on research into new bio-health materials and technologies. It develops, manufactures and sells health functional foods, quasi-drugs, health-oriented foods and microbiome products, and provides CDMO services for MFDS-individually recognized raw materials, along with DTC genetic testing and home beauty devices. Its main customers include TV home shopping channels, e-commerce platforms, B2B partners and overseas buyers in markets such as the United States, Japan, China, Europe and Southeast Asia.
What is the market cap of Hlscience?
The market capitalisation of Hlscience was ₩29B at the close on Oct 27, 2026.
Who are the largest shareholders of Hlscience?
According to the latest official filings, the largest reported holders are Lee Hae-yeon (64.27%, as of Mar 11, 2026); Lee Dong-hyeon (27.15%, as of May 6, 2026); National Pension Service (1.00%, as of Dec 31, 2019).
When is the next earnings report from Hlscience?
Korean companies rarely announce results dates in advance. Based on when Hlscience filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Does the National Pension Service own Hlscience?
Yes. The National Pension Service held 1.00% of Hlscience shares as of Dec 31, 2019.

Company profile

The company is a bio-healthcare technology platform focused on research into new bio-health materials and technologies. It develops, manufactures and sells health functional foods, quasi-drugs, health-oriented foods and microbiome products, and provides CDMO services for MFDS-individually recognized raw materials, along with DTC genetic testing and home beauty devices. Its main customers include TV home shopping channels, e-commerce platforms, B2B partners and overseas buyers in markets such as the United States, Japan, China, Europe and Southeast Asia.

Written by AI from the company's latest annual report.

Korean name
에이치엘사이언스
CEO
이해연
Founded
Sep 2000
Listed
Oct 2016
Listed shares
5,392,115
Fiscal year ends
Month 12

Similar companies

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: Hlscience / 에이치엘사이언스 / 239610 / KRX:239610

Source: KRX statistical information